Ryhim
12 posts

Ryhim retweetledi
Ryhim retweetledi
Ryhim retweetledi
Ryhim retweetledi

🚨 This triggers an internal immune sensor that destroys HIV from within.
For decades, the primary hurdle in curing HIV has been the virus’s ability to weave its genetic code into human cells and remain dormant, effectively hiding from both the immune system and standard medications. However, researchers have identified a way to exploit an internal immune sensor called CARD8. Normally, HIV evades this sensor by delaying the activation of its protease enzymes until it has already exited the host cell. New research shows that a class of drugs known as targeted activators of cell kill (TACK) can force these enzymes to activate prematurely while still inside. This “trips the alarm,” causing the infected cell to undergo pyroptosis—a form of programmed cell suicide—before it can release new copies of the virus into the bloodstream.
Early clinical evidence has already shown significant promise, with a recent study involving human participants demonstrating a 20% to 50% reduction in hidden viral reservoirs after just four months of treatment. While this is not yet a total cure, the proof-of-principle suggests that depleting these reservoirs could eventually lead to a "functional cure," allowing patients to control the virus without lifelong medication. Beyond a total cure, these TACK molecules could drastically improve long-term health by reducing the chronic inflammation linked to heart disease and cancer in survivors. Major pharmaceutical developers are now accelerating the testing of even more potent molecules, marking a pivotal shift in the global effort to finally eliminate the HIV epidemic.
Source: Cohen, J. (2026). New HIV cure approach forces hidden virus into tripping immune sensor. Science.

English
Ryhim retweetledi
Ryhim retweetledi
















